Latest news

Researchers assessed whether a ketogenic diet, low in carbohydrates and high in fats, is suitable for people with multiple sclerosis.

Roxy talks about her MS journey and the importance of sharing her own experiences to ensure that others don’t face the same challenges when receiving a diagnosis.

With confusion around eligibility and access to covid medicines, we heard personal experiences from our online community.

In May 2022, Lis will be heading off on her 5,000 mile cycling challenge. She shares how the idea came about and discusses why the support of the MS Trust was invaluable following a multiple sclerosis diagnosis.

NHS England has agreed that Mayzent can be prescribed for people with active secondary progressive multiple sclerosis whose disability has increased for at least 6 months, unrelated to relapses, and while taking a disease modifying drug.

New report from the MS Trust highlights the importance of accessible care for people living with MS.

Researchers have investigated whether the benefits of early treatment, which are well-established for disease modifying drugs, could also be applied to exercise therapy.

Multiple sclerosis and Epstein-Barr virus have been in the news with reports of new avenues for treatment. But how quickly might we see new treatments or cures?

Vumerity (diroximel fumarate) has been approved by NICE for people with active relapsing remitting multiple sclerosis.

Siblings Patsy and Connor talk about Patsy's diagnosis with MS at the age of 14 and why Connor is taking part in the Great North Run in support of the MS Trust. 

Find out how the fundraising team got on at the Annual MS Trust Conference. 

People with MS can get effective treatments if they get Covid-19. This article explains more about molnupiravir (Lagevrio) and sotrovimab (Xetrudy) and how to get them if you catch coronavirus.